Table 1 Baseline characteristics
Complete study population (n = 62) | Group SAD (n = 20) | Group D (n = 18) | Group D + SAD (n = 24) | p value | |
|---|---|---|---|---|---|
Age in years (SD) | 53.5 (9.0) | 52.7 (10.1) | 54.9 (7.7) | 53.2 (8.8) | 0.82 |
Gender male (%) | 21 (33.9) | 7 (35.0) | 3 (16.7) | 11 (45.8) | 0.13* |
Affected side Right (%) | 47 (75.8) | 15 (75.0) | 16 (88.9) | 16 (66.7) | 0.24* |
Dominant side Right (%) | 46 (74.2) | 14 (70.0) | 16 (88.9) | 16 (66.7) | 0.20* |
Smoking status smoking (%) | 18 (29.0) | 6 (20.0) | 3 (16.7) | 9 (37.5) | 0.48* |
ASA category | |||||
1 (%) | 26 (41.9) | 8 (40.0) | 8 (44.4) | 10 (41.7) | 0.99* |
2 (%) | 32 (51.6) | 10 (50.0) | 11 (61.1) | 11 (45.8) | |
3 (%) | 4 (6.5) | 1 (5.0) | 1 (5.6) | 2 (8.3) | |
BMI Mean (SD) | 26.7 (4.3) | 26.4 (4.5) | 26 (3.5) | 27.3 (4.7) | 0.78 |
Comorbidities | |||||
Pulmonary (%) | 12 (19.4) | 4 (20.0) | 1 (5.6) | 7 (29.2) | 0.21 |
Cardiovascular (e.g., HT, hyperlipidemia) | 9 (14.5) | 2 (10.0) | 3 (16.7) | 4 (16.7) | 0.91 |
Thyroid dysfunction | 2 (3.2) | 0 | 1 (5.6) | 1 (4.2) | NA |
Diabetes mellitus | 1 (1.6) | 0 | 0 | 1 (4.2) | NA |
Duration of symptoms in months (range) | 22.2 (6–120) | 17.1 (6–120) | 20.3 (6–120) | 24.7 (6–120) | 0.57+ |
Size of deposit in mm | 23.0 (7.6) | 23.4 (6.0) | 24.7 (7.3) | 21.3 (8.6) | 0.34 |
Bosworth grade | |||||
II, medium (%) | 5 (8.1) | 1 (5) | 0 | 4 (16.7) | 0.34 |
III, large (%) | 57 (91.9) | 19 (95) | 18 (100.0) | 20 (83.3) | |
Gartner type | |||||
Type I (%) | 39 (62.9) | 15 (75.0) | 11 (61.1) | 13 (54.2) | 0.62* |
Type II (%) | 23 (37.1) | 5 (25.0) | 7 (38.9) | 11 (45.8) | |
Location of deposit | |||||
SSP (%) | 54 (87.1) | 17 (85.0) | 16 (88.9) | 21 (87.5) | 0.87* |
ISP (%) | 8 (12.9) | 3 (15.0) | 2 (11.1) | 3 (12.5) | |
SSC (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |